The company’s adjusted EBIT bridge illustrates how positive economic sales growth of €52 million was offset by increased logistics network costs (€50 million), commercial costs (€6 million), and ...
Mycronic (STO:MYCR) reported a stellar first quarter for 2025, achieving record sales and EBIT figures while navigating varying performance across its divisions. The company’s stock closed at SEK 381 ...
Despite the revenue decline, EBIT improved dramatically to €4.9 million (3.0% margin), representing a 445% increase from €1.1 million (0.6% margin) in the same period last year. The company’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback